相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)
William M. Sikov et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Subclonal diversification of primary breast cancer revealed by multiregion sequencing
Lucy R. Yates et al.
NATURE MEDICINE (2015)
Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial
H. Bonnefoi et al.
ANNALS OF ONCOLOGY (2014)
Quantitative assessment Ki-67 score for prediction of response to neoadjuvant chemotherapy in breast cancer
Jason R. Brown et al.
LABORATORY INVESTIGATION (2014)
Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44)
B. Gerber et al.
ANNALS OF ONCOLOGY (2013)
Tumour-infiltrating CD8+lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer
A. N. Seo et al.
BRITISH JOURNAL OF CANCER (2013)
Prognostic and Predictive Value of Tumor Vascular Endothelial Growth Factor Gene Amplification in Metastatic Breast Cancer Treated with Paclitaxel with and without Bevacizumab; Results from ECOG 2100 Trial
Bryan P. Schneider et al.
CLINICAL CANCER RESEARCH (2013)
Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer
Manfred Kaufmann et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Copynumber: Efficient algorithms for single- and multi-track copy number segmentation
Gro Nilsen et al.
BMC GENOMICS (2012)
The Life History of 21 Breast Cancers
Serena Nik-Zainal et al.
CELL (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer
Harry D. Bear et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Allele-specific copy number analysis of tumors
Peter Van Loo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Relative impact of nucleotide and copy number variation on gene expression phenotypes
Barbara E. Stranger et al.
SCIENCE (2007)
Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases
D. P. Lesslie et al.
BRITISH JOURNAL OF CANCER (2006)
Breast cancer molecular subtypes respond differently to preoperative chemotherapy
R Rouzier et al.
CLINICAL CANCER RESEARCH (2005)
Endothelial cell-cell junctions: Happy together
E Dejana
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer
JC Chang et al.
LANCET (2003)
p38 MAP kinase -: a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability
K Issbrücker et al.
FASEB JOURNAL (2002)